Boston Scientific Surges As It Looks To Enter A Nearly $8 Billion Market

is likely to win Food and Drug Administration approval for a new method of treating abnormal heartbeats, analysts said Monday. BSX stock surged on news. The company tested a method known as pulsed field ablation in patients with atrial fibrillation, or a type of abnormal heartbeat. Pulsed field…#bsx #bostonscientific #ubs #danielleantalffy #needham #mikematson #johnsonjohnson #jnj #allisongatlin #twitter
Source: Reuters: Health - Category: Consumer Health News Source Type: news